Xinhua News Agency, London, August 20 (Reporter Zhang Jiawei) The University of Oxford recently announced a study showing that the new crown vaccine jointly developed by AstraZeneca Pharmaceuticals and Oxford University used in the UK, as well as Pfizer Pharmaceuticals Co.
The school conducted this research in cooperation with the National Bureau of Statistics of the United Kingdom and the Department of Health of the United Kingdom
The results of the study show that both AstraZeneca vaccine and Pfizer vaccine can play a protective effect against the delta strain after two doses, but its protective effect is lower than that against the mutant new crown virus alpha strain.
The lead author of the research report, Cohen Pwells of Oxford University, said that vaccination can reduce the probability of contracting the new crown virus, but it will not eliminate the new crown virus encountered by vaccinators
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
